Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

Aurora Cannabis Inc.NASDAQ: ACB

EPS (Diluted) · Q4 FY2026 · quarter ended Mar 2026

EPS (Diluted) remains negative

Q4 FY2026 EPS (Diluted) was -CA$0.99, compared with -CA$0.44 a year earlier. Trailing-twelve-month EPS (Diluted) was -CA$2.23.

Context

  • EPS (Diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 2 analysts of -CA$0.47 (+78.2%) for the fiscal year ending Mar 2027, a step up from the -7643.9% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$0.99-3213.2% QoQ
Last fiscal yearMar 2026
-CA$2.15-7643.9% YoY
LTMMar 2026
-CA$2.23-4556.4% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-125.0%+49.2%+174.2 pp
1 year-7643.9%+78.2%+7722.0 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

CAD · from the income statement

Latest · FY2026
(2.15) CAD
Year-over-year change
-7643.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How ACB compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -4556.4% is the lowest of 10, against a peer median of +35.2%.
ACB Competitors
EPS (Diluted) for ACB and competitors
Company Period LTM YoY 3-year CAGR
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026$0.6 USD+400.9%-46.1%
OGIOrganigram Global Inc.LTM Mar 2026-CA$0.18 CAD-291.9%—
TKNOAlpha Teknova, Inc.LTM Mar 2026-$0.32 USD+35.2%—
LFMDLifeMD, Inc.LTM Mar 2026-$0.41 USD-30.1%—
HITIHigh Tide Inc.LTM Apr 2026-CA$0.5 CAD-607.5%—
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-$0.56 USD+59.7%—
CGCCanopy Growth CorporationLTM Mar 2026-CA$0.88 CAD+84.4%—
LFCRLifecore Biomedical, Inc.LTM Mar 2026-$1.03 USD——
EDITEditas Medicine, Inc.LTM Mar 2026-$1.23 USD+59.6%—
ACBAurora Cannabis Inc.LTM Mar 2026-CA$2.23 CAD-4556.4%—
BIOABioAge Labs, Inc.LTM Mar 2026-$2.4 USD-18.2%—
Peer median (excluding ACB) —+35.2%-46.1%

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M223.8M270.28M343.29M321.42M
Cost of Revenue200.11M209.02M138.82M155.69M304.67M
Gross Profit21.23M14.78M131.46M187.61M16.75M
Gross Margin9.6%6.6%48.6%54.6%5.2%
Research & Development10.39M5.77M3.57M3.68M6.01M
Selling, General & Admin188.99M170.48M156.88M166.47M173.95M
Operating Expenses252.67M221.98M177.91M182.66M179.96M
Depreciation & Amortization93.66M52.59M33.07M22.55M14.23M
EBITDA(1.55B)(135M)(12.34M)51.35M(148.99M)
EBITDA Margin-702.4%-60.3%-4.6%15.0%-46.4%
Operating Income(231.45M)(207.19M)(46.45M)4.95M(163.21M)
Operating Margin-104.6%-92.6%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.86M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(576.51M)(13.15M)15.43M106.54M
Income Before Tax(1.72B)(783.7M)(59.6M)20.38M(56.67M)
Pre-Tax Margin-777.1%-350.2%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)16.55M(554K)4.62M2.1M
Net Income(1.72B)(816.63M)(69.33M)1.59M(122.07M)
Net Margin-776.0%-364.9%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.